911069-01-7

Basic information

• Product Name: Butanoic acid, 4-oxo-3-[[(phenylmethoxy)carbonyl]amino]-4-[[(1S)-1-[3-(trifluoromethyl) phenyl]ethyl]amino]-, 1,1-dimethylethyl ester, (3R)-
• CAS NO: 911069-01-7
• Molecular Formula: C25H29F3N2O5
• Molecular Weight: 494.511
• Mol File: 911069-01-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 4-oxo-3-[[(phenylmethoxy)carbonyl]amino]-4-[[(1S)-1-[3-(trifluoromethyl) phenyl]ethyl]amino]-, 1,1-dimethylethyl ester, (3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 4-oxo-3-[[(phenylmethoxy)carbonyl]amino]-4-[[(1S)-1-[3-(trifluoromethyl) phenyl]ethyl]amino]-, 1,1-dimethylethyl ester, (3R)-(911069-01-7)
• EPA Substance Registry System: Butanoic acid, 4-oxo-3-[[(phenylmethoxy)carbonyl]amino]-4-[[(1S)-1-[3-(trifluoromethyl) phenyl]ethyl]amino]-, 1,1-dimethylethyl ester, (3R)-(911069-01-7)

Safety Data

• Hazardous Substances Data: 911069-01-7(Hazardous Substances Data)

Upstream product

• 127852-21-5 (S)-α-(m-(trifluoromethyl)phenyl)ethylamine 
• 71449-08-6 (2R)-2-{[(benzyloxy)carbonyl]amino}-4-tert-butoxy-4-oxobutanoic acid 

Downstream Products

• 911068-21-8 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-[1-(3-trifluoromethyl-phenyl)-ethyl]-succinamic acid tert-butyl ester 
• 911068-31-0 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-[1-(3-trifluoromethyl-phenyl)-ethyl]-succinamic acid 
• 911069-04-0 D-aspartic acid β-tert-butyl ester α-{[(S)-1-(trifluoromethyl)phenyl]ethyl}amide 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY

Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.

METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER

Compounds and compositions are described herein for treating post tramatic stress disorder.

Azetidinones as vasopressin V1a antagonists

The azetidinone LY307174 (1) was identified as a screening lead for the vasopressin V1a receptor (IC50 45 nM at the human V1a receptor) based on molecular similarity to ketoconazole (2), a known antagonist of the luteinizing hormone releasing h